FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1555752669> ?p ?o ?g. }

• W1555752669 endingPage "1372" @default.
• W1555752669 startingPage "1364" @default.
• W1555752669 abstract "Abstract This study consists of 65 patients (pts) who developed a myelodysplastic syndrome (MDS) (39 pts) or acute myeloid leukemia (AML) (26 pts) following chemotherapy and/or radiotherapy; the interval from the onset of therapy to bone marrow abnormality ranged from 11 to 192 months (median, 58). Thirty-three patients had been previously treated for lymphoproliferative diseases, 29 for carcinoma, and three for a nonneoplastic disorder. Approximately 30% of the cases presenting in the MDS phase evolved to AML in one to 12 months (median, 3.5). The AML in 49% of the cases was not readily classified according to French- American-British (FAB) criteria; the primary difficulty in classification related to the involvement of multiple cell lines. Among the cases that could be classified, all FAB types were represented except for M1; M2 was the most frequent type. Clonal chromosome abnormalities were found in marrow specimens from 22 of 24 (92%) patients studied with G banding; 11 had abnormalities of chromosomes 5 and/or 7. The median survival for all patients was four months with no significant difference between those treated and not treated with antileukemic therapy. The median survival was three months for the patients presenting with AML, six months for the patients with AML following an MDS, and four months for the patients with an MDS that did not evolve to AML. The findings in the present study suggest that there are three stages of therapy-related panmyelosis: (1) pancytopenia with associated myelodysplastic changes, (2) a frank MDS, and (3) overt AML. Many patients will present in the stage of overt AML that differs from de novo AML primarily by the high incidence of trilineage involvement, difficulty in classification, frequent cytogenetic abnormalities, and poor response to antileukemic therapy. The myelodysplastic phase, with or without evolution to acute leukemia, is a highly lethal disease with a median survival comparable to that of the patients who present with AML." @default.
• W1555752669 created "2016-06-24" @default.
• W1555752669 creator A5024634894 @default.
• W1555752669 creator A5026277262 @default.
• W1555752669 creator A5052071909 @default.
• W1555752669 creator A5061379753 @default.
• W1555752669 date "1985-06-01" @default.
• W1555752669 modified "2023-10-16" @default.
• W1555752669 title "Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases" @default.
• W1555752669 cites W117025758 @default.
• W1555752669 cites W1719540238 @default.
• W1555752669 cites W1987422706 @default.
• W1555752669 cites W2011632472 @default.
• W1555752669 cites W2030916937 @default.
• W1555752669 cites W2048791678 @default.
• W1555752669 cites W2049730439 @default.
• W1555752669 cites W2055665512 @default.
• W1555752669 cites W2060988243 @default.
• W1555752669 cites W2068306068 @default.
• W1555752669 cites W2069473208 @default.
• W1555752669 cites W2083492673 @default.
• W1555752669 cites W2091521731 @default.
• W1555752669 cites W2091924177 @default.
• W1555752669 cites W2148477394 @default.
• W1555752669 cites W2163959245 @default.
• W1555752669 cites W2329211716 @default.
• W1555752669 cites W2330620447 @default.
• W1555752669 cites W2331042177 @default.
• W1555752669 cites W2340198921 @default.
• W1555752669 cites W2400925245 @default.
• W1555752669 cites W2414417418 @default.
• W1555752669 cites W2414842751 @default.
• W1555752669 cites W2463841727 @default.
• W1555752669 cites W29652067 @default.
• W1555752669 cites W3111856753 @default.
• W1555752669 cites W1983392832 @default.
• W1555752669 doi "https://doi.org/10.1182/blood.v65.6.1364.bloodjournal6561364" @default.
• W1555752669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3857944" @default.
• W1555752669 hasPublicationYear "1985" @default.
• W1555752669 type Work @default.
• W1555752669 sameAs 1555752669 @default.
• W1555752669 citedByCount "307" @default.
• W1555752669 countsByYear W15557526692012 @default.
• W1555752669 countsByYear W15557526692013 @default.
• W1555752669 countsByYear W15557526692014 @default.
• W1555752669 countsByYear W15557526692015 @default.
• W1555752669 countsByYear W15557526692016 @default.
• W1555752669 countsByYear W15557526692017 @default.
• W1555752669 countsByYear W15557526692018 @default.
• W1555752669 countsByYear W15557526692019 @default.
• W1555752669 countsByYear W15557526692020 @default.
• W1555752669 countsByYear W15557526692022 @default.
• W1555752669 crossrefType "journal-article" @default.
• W1555752669 hasAuthorship W1555752669A5024634894 @default.
• W1555752669 hasAuthorship W1555752669A5026277262 @default.
• W1555752669 hasAuthorship W1555752669A5052071909 @default.
• W1555752669 hasAuthorship W1555752669A5061379753 @default.
• W1555752669 hasBestOaLocation W15557526691 @default.
• W1555752669 hasConcept C104317684 @default.
• W1555752669 hasConcept C126322002 @default.
• W1555752669 hasConcept C143998085 @default.
• W1555752669 hasConcept C185592680 @default.
• W1555752669 hasConcept C2776694085 @default.
• W1555752669 hasConcept C2778461978 @default.
• W1555752669 hasConcept C2778729363 @default.
• W1555752669 hasConcept C2779282312 @default.
• W1555752669 hasConcept C2779382419 @default.
• W1555752669 hasConcept C2780007613 @default.
• W1555752669 hasConcept C2780189214 @default.
• W1555752669 hasConcept C2780817109 @default.
• W1555752669 hasConcept C30481170 @default.
• W1555752669 hasConcept C509974204 @default.
• W1555752669 hasConcept C53226629 @default.
• W1555752669 hasConcept C55493867 @default.
• W1555752669 hasConcept C71924100 @default.
• W1555752669 hasConcept C90924648 @default.
• W1555752669 hasConceptScore W1555752669C104317684 @default.
• W1555752669 hasConceptScore W1555752669C126322002 @default.
• W1555752669 hasConceptScore W1555752669C143998085 @default.
• W1555752669 hasConceptScore W1555752669C185592680 @default.
• W1555752669 hasConceptScore W1555752669C2776694085 @default.
• W1555752669 hasConceptScore W1555752669C2778461978 @default.
• W1555752669 hasConceptScore W1555752669C2778729363 @default.
• W1555752669 hasConceptScore W1555752669C2779282312 @default.
• W1555752669 hasConceptScore W1555752669C2779382419 @default.
• W1555752669 hasConceptScore W1555752669C2780007613 @default.
• W1555752669 hasConceptScore W1555752669C2780189214 @default.
• W1555752669 hasConceptScore W1555752669C2780817109 @default.
• W1555752669 hasConceptScore W1555752669C30481170 @default.
• W1555752669 hasConceptScore W1555752669C509974204 @default.
• W1555752669 hasConceptScore W1555752669C53226629 @default.
• W1555752669 hasConceptScore W1555752669C55493867 @default.
• W1555752669 hasConceptScore W1555752669C71924100 @default.
• W1555752669 hasConceptScore W1555752669C90924648 @default.
• W1555752669 hasIssue "6" @default.
• W1555752669 hasLocation W15557526691 @default.
• W1555752669 hasOpenAccess W1555752669 @default.
• W1555752669 hasPrimaryLocation W15557526691 @default.

• next